If it is effective with multiple CAR-T therapies, which is likely since all of their toxicity issues stem from GM-CSF, the buyout price will be astronomical.
Haha... Okay, sure.
BTW, who is to going to buyout HGEN and at an astronomical price? Because there is nobody circling the wagon.